Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells.

Wang Q, Robinette ML, Billon C, Collins PL, Bando JK, Fachi JL, Sécca C, Porter SI, Saini A, Gilfillan S, Solt LA, Musiek ES, Oltz EM, Burris TP, Colonna M.

Sci Immunol. 2019 Oct 4;4(40). pii: eaay7501. doi: 10.1126/sciimmunol.aay7501.

PMID:
31586012
2.

Circadian regulation of astrocyte function: implications for Alzheimer's disease.

McKee CA, Lananna BV, Musiek ES.

Cell Mol Life Sci. 2019 Sep 27. doi: 10.1007/s00018-019-03314-y. [Epub ahead of print] Review.

PMID:
31578625
3.

Rev-erbs and Glia-Implications for Neurodegenerative Diseases.

Griffin P, Dimitry JM, Musiek ES.

J Exp Neurosci. 2019 Jun 4;13:1179069519853233. doi: 10.1177/1179069519853233. eCollection 2019.

4.

Correction: Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the ω -3 polyunsaturated fatty acid docosahexaenoic acid.

Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD.

J Biol Chem. 2019 Apr 19;294(16):6657. doi: 10.1074/jbc.AAC119.008639. No abstract available.

5.

Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease.

Roby DA, Ruiz F, Kermath BA, Voorhees JR, Niehoff M, Zhang J, Morley JE, Musiek ES, Farr SA, Burris TP.

PLoS One. 2019 Apr 11;14(4):e0215004. doi: 10.1371/journal.pone.0215004. eCollection 2019.

6.

Dural lymphatics regulate clearance of extracellular tau from the CNS.

Patel TK, Habimana-Griffin L, Gao X, Xu B, Achilefu S, Alitalo K, McKee CA, Sheehan PW, Musiek ES, Xiong C, Coble D, Holtzman DM.

Mol Neurodegener. 2019 Feb 27;14(1):11. doi: 10.1186/s13024-019-0312-x.

7.

Circadian clock protein Rev-erbα regulates neuroinflammation.

Griffin P, Dimitry JM, Sheehan PW, Lananna BV, Guo C, Robinette ML, Hayes ME, Cedeño MR, Nadarajah CJ, Ezerskiy LA, Colonna M, Zhang J, Bauer AQ, Burris TP, Musiek ES.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5102-5107. doi: 10.1073/pnas.1812405116. Epub 2019 Feb 21.

8.

Association between circadian rhythms and neurodegenerative diseases.

Leng Y, Musiek ES, Hu K, Cappuccio FP, Yaffe K.

Lancet Neurol. 2019 Mar;18(3):307-318. doi: 10.1016/S1474-4422(18)30461-7. Epub 2019 Feb 12. Review.

PMID:
30784558
9.

Cell-Autonomous Regulation of Astrocyte Activation by the Circadian Clock Protein BMAL1.

Lananna BV, Nadarajah CJ, Izumo M, Cedeño MR, Xiong DD, Dimitry J, Tso CF, McKee CA, Griffin P, Sheehan PW, Haspel JA, Barres BA, Liddelow SA, Takahashi JS, Karatsoreos IN, Musiek ES.

Cell Rep. 2018 Oct 2;25(1):1-9.e5. doi: 10.1016/j.celrep.2018.09.015.

10.

Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Day GS, Musiek ES, Morris JC.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):291-297. doi: 10.1097/WAD.0000000000000276.

11.

Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.

Vanderheyden WM, Lim MM, Musiek ES, Gerstner JR.

J Neurosci. 2018 Mar 21;38(12):2901-2910. doi: 10.1523/JNEUROSCI.1135-17.2017. Review.

12.

In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, Morris JC, Benzinger TLS, Ances BM.

Neurology. 2018 Mar 6;90(10):e896-e906. doi: 10.1212/WNL.0000000000005064. Epub 2018 Feb 7.

13.

Regulation of amyloid-β dynamics and pathology by the circadian clock.

Kress GJ, Liao F, Dimitry J, Cedeno MR, FitzGerald GA, Holtzman DM, Musiek ES.

J Exp Med. 2018 Apr 2;215(4):1059-1068. doi: 10.1084/jem.20172347. Epub 2018 Jan 30.

14.

Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.

Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS.

JAMA Neurol. 2018 May 1;75(5):582-590. doi: 10.1001/jamaneurol.2017.4719.

15.

Circadian Rhythms in AD pathogenesis: A Critical Appraisal.

Musiek ES.

Curr Sleep Med Rep. 2017 Jun;3(2):85-92. doi: 10.1007/s40675-017-0072-5. Epub 2017 Apr 22.

16.

Sleep and clocks - implications for brain health.

Musiek ES, Videnovic A.

Neurobiol Sleep Circadian Rhythms. 2017 Jan 5;2:1-3. doi: 10.1016/j.nbscr.2016.12.001. eCollection 2017 Jan. No abstract available.

17.

Mechanisms linking circadian clocks, sleep, and neurodegeneration.

Musiek ES, Holtzman DM.

Science. 2016 Nov 25;354(6315):1004-1008. Review.

18.

Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy.

Musiek ES, Xiong DD, Patel T, Sasaki Y, Wang Y, Bauer AQ, Singh R, Finn SL, Culver JP, Milbrandt J, Holtzman DM.

Ann Clin Transl Neurol. 2016 May 6;3(6):434-42. doi: 10.1002/acn3.308. eCollection 2016 Jun.

19.

Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.

Day GS, Musiek ES, Roe CM, Norton J, Goate AM, Cruchaga C, Cairns NJ, Morris JC.

JAMA Neurol. 2016 Sep 1;73(9):1125-32. doi: 10.1001/jamaneurol.2016.1236.

20.

Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.

Yang G, Chen L, Grant GR, Paschos G, Song WL, Musiek ES, Lee V, McLoughlin SC, Grosser T, Cotsarelis G, FitzGerald GA.

Sci Transl Med. 2016 Feb 3;8(324):324ra16. doi: 10.1126/scitranslmed.aad3305. Epub 2016 Feb 3.

21.

Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Musiek ES, Holtzman DM.

Nat Neurosci. 2015 Jun;18(6):800-6. doi: 10.1038/nn.4018. Review.

22.

Circadian clock disruption in neurodegenerative diseases: cause and effect?

Musiek ES.

Front Pharmacol. 2015 Feb 27;6:29. doi: 10.3389/fphar.2015.00029. eCollection 2015.

23.

Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease.

Musiek ES, Xiong DD, Holtzman DM.

Exp Mol Med. 2015 Mar 13;47:e148. doi: 10.1038/emm.2014.121. Review.

24.

Alzheimer disease: current concepts & future directions.

Musiek ES, Schindler SE.

Mo Med. 2013 Sep-Oct;110(5):395-400. Review.

25.

Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration.

Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, Roh JH, Ortiz-Gonzalez X, Dearborn JT, Culver JP, Herzog ED, Hogenesch JB, Wozniak DF, Dikranian K, Giasson BI, Weaver DR, Holtzman DM, Fitzgerald GA.

J Clin Invest. 2013 Dec;123(12):5389-400. doi: 10.1172/JCI70317. Epub 2013 Nov 25.

26.

Knitting up the raveled sleave of care.

Yang G, Paschos G, Curtis AM, Musiek ES, McLoughlin SC, FitzGerald GA.

Sci Transl Med. 2013 Nov 20;5(212):212rv3. doi: 10.1126/scitranslmed.3007225. Review.

PMID:
24259052
27.

Molecular clocks in pharmacology.

Musiek ES, Fitzgerald GA.

Handb Exp Pharmacol. 2013;(217):243-60. doi: 10.1007/978-3-642-25950-0_10. Review.

28.

Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.

Musiek ES, Saboury B, Mishra S, Chen Y, Reddin JS, Newberg AB, Udupa JK, Detre JA, Hofheinz F, Torigian D, Alavi A.

Hell J Nucl Med. 2012 Sep-Dec;15(3):190-6. doi: 10.1967/s002449910052. Epub 2012 Oct 25.

29.
30.

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.

Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA.

Neurology. 2011 Nov 29;77(22):1977-85. doi: 10.1212/WNL.0b013e31823a0ef7. Epub 2011 Nov 16.

31.

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA.

Alzheimers Dement. 2012 Jan;8(1):51-9. doi: 10.1016/j.jalz.2011.06.003. Epub 2011 Oct 21.

32.

The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation.

Brooks JD, Musiek ES, Koestner TR, Stankowski JN, Howard JR, Brunoldi EM, Porta A, Zanoni G, Vidari G, Morrow JD, Milne GL, McLaughlin B.

J Neurochem. 2011 Nov;119(3):604-16. doi: 10.1111/j.1471-4159.2011.07422.x. Epub 2011 Sep 23.

33.

p66(shc)'s role as an essential mitophagic molecule in controlling neuronal redox and energetic tone.

Kleman AM, Brown JE, Zeiger SL, Hettinger JC, Brooks JD, Holt B, Morrow JD, Musiek ES, Milne GL, McLaughlin B.

Autophagy. 2010 Oct;6(7):948-9. doi: 10.1523/j.neurosci.6366-09.2010. Epub 2010 Oct 14.

34.

Facial tic associated with lamotrigine in adults.

Musiek ES, Anderson CT, Dahodwala NA, Pollard JR.

Mov Disord. 2010 Jul 30;25(10):1512-3. doi: 10.1002/mds.23120. No abstract available.

PMID:
20629145
35.

Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning.

Brown JE, Zeiger SL, Hettinger JC, Brooks JD, Holt B, Morrow JD, Musiek ES, Milne G, McLaughlin B.

J Neurosci. 2010 Apr 14;30(15):5242-52. doi: 10.1523/JNEUROSCI.6366-09.2010.

36.

Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.

Zeiger SL, Musiek ES, Zanoni G, Vidari G, Morrow JD, Milne GJ, McLaughlin B.

Free Radic Biol Med. 2009 Nov 15;47(10):1422-31. doi: 10.1016/j.freeradbiomed.2009.08.011. Epub 2009 Aug 19.

37.

Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.

Yang L, Calingasan NY, Thomas B, Chaturvedi RK, Kiaei M, Wille EJ, Liby KT, Williams C, Royce D, Risingsong R, Musiek ES, Morrow JD, Sporn M, Beal MF.

PLoS One. 2009 Jun 1;4(6):e5757. doi: 10.1371/journal.pone.0005757.

38.

Investigation of Nonneoplastic Neurologic Disorders with PET and MRI.

Musiek ES, Torigian DA, Newberg AB.

PET Clin. 2008 Jul;3(3):317-34. doi: 10.1016/j.cpet.2009.01.003. Epub 2009 Jun 21. Review.

PMID:
27156664
39.

Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid.

Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD.

J Biol Chem. 2008 Jul 18;283(29):19927-35. doi: 10.1074/jbc.M803625200. Epub 2008 May 19. Erratum in: J Biol Chem. 2019 Apr 19;294(16):6657.

40.

Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain.

Cuddihy SL, Ali SS, Musiek ES, Lucero J, Kopp SJ, Morrow JD, Dugan LL.

J Biol Chem. 2008 Mar 14;283(11):6915-24. doi: 10.1074/jbc.M702572200. Epub 2008 Jan 7.

41.

Electrophilic cyclopentenone isoprostanes in neurodegeneration.

Musiek ES, McLaughlin B, Morrow JD.

J Mol Neurosci. 2007 Sep;33(1):80-6. Review.

42.

Quantification of F2-isoprostanes as a biomarker of oxidative stress.

Milne GL, Sanchez SC, Musiek ES, Morrow JD.

Nat Protoc. 2007;2(1):221-6.

PMID:
17401357
43.

Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Musiek ES, Breeding RS, Milne GL, Zanoni G, Morrow JD, McLaughlin B.

J Neurochem. 2006 Jun;97(5):1301-13. Epub 2006 Apr 21.

44.

Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.

Musiek ES, Yin H, Milne GL, Morrow JD.

Lipids. 2005 Oct;40(10):987-94. Review.

PMID:
16382569
45.

F2-isoprostanes as markers of oxidative stress in vivo: an overview.

Milne GL, Musiek ES, Morrow JD.

Biomarkers. 2005 Nov;10 Suppl 1:S10-23. Review.

PMID:
16298907
46.

Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.

Musiek ES, Gao L, Milne GL, Han W, Everhart MB, Wang D, Backlund MG, DuBois RN, Zanoni G, Vidari G, Blackwell TS, Morrow JD.

J Biol Chem. 2005 Oct 21;280(42):35562-70. Epub 2005 Aug 12.

47.

Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.

Musiek ES, Morrow JD.

Curr Protoc Toxicol. 2005 Jun;Chapter 17:Unit 17.6. doi: 10.1002/0471140856.tx1706s24.

PMID:
23045115
48.

F2-isoprostanes as markers of oxidant stress: an overview.

Musiek ES, Morrow JD.

Curr Protoc Toxicol. 2005 Jun;Chapter 17:Unit 17.5. doi: 10.1002/0471140856.tx1705s24. Review.

PMID:
23045114
49.
50.

Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.

Yin H, Musiek ES, Gao L, Porter NA, Morrow JD.

J Biol Chem. 2005 Jul 15;280(28):26600-11. Epub 2005 May 13.

Supplemental Content

Loading ...
Support Center